We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Let’s try this again

28 March 2018 By Robert Cyran, Neil Unmack

The $42 bln Japanese drugs group may bid for $45 bln takeover machine Shire. There’s not much overlap, and uncertainties hang over key businesses. But Shire is cheap, and its shareholders exasperated. That may appeal to Takeda boss Christophe Weber, but it’s also a warning.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)